Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Repression of transcription of the p27Kip1 cyclin-dependent kinase inhibitor gene by c-Myc

Oncogene volume 20, pages 1688–1702 (2001)Cite this article

Abstract

Upon engagement of the B Cell Receptor (BCR) of WEHI 231 immature B cells, a drop in c-Myc expression is followed by activation of the cyclin-dependent kinase inhibitor (CKI) p27Kip1, which induces growth arrest and apoptosis. Here, we report inverse patterns of p27 and c-Myc protein expression follow BCR engagement. We present evidence demonstrating, for the first time, that the p27Kip1 gene is a target of transcriptional repression by c-Myc. Specifically, the changes in p27 protein levels correlated with changes in p27 mRNA levels, and gene transcription. Induction of p27 promoter activity followed BCR engagement of WEHI 231 cells, and this induction could be repressed upon co-transfection of a c-Myc expression vector. Inhibition of the TATA-less p27 promoter by c-Myc was also observed in Jurkat T cells, vascular smooth muscle, and Hs578T breast cancer cells, extending the observation beyond immune cells. Consistent with a putative Inr element CCAGACC (where +1 is underlined) at the start site of transcription in the p27 promoter, deletion of Myc homology box II reduced the extent of repression. Furthermore, enhanced repression was observed upon transfection of the c-Myc ‘super-repressor’, with mutation of Phe115 to Leu. The sequences mediating transcriptional activity and c-Myc repression were mapped to bp −20 to +20 of the p27 gene. Finally, binding of Max was shown to facilitate c-Myc binding and repression of p27 promoter activity. Overall, these studies identify the p27 CKI gene as a new target whereby c-Myc can control cell proliferation, survival and neoplastic transformation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H . 1993 Cell 72: 233–245

  • Amundson SA, Zhan Q, Penn LZ, Fornace AJ . 1998 Oncogene 17: 2149–2154

  • Arsura M, Hofmann CS, Golay J, Introna M, Sonenshein GE . 2000 Blood 96: 1013–1020

  • Arsura M, Deshpande A, Hann SR, Sonenshein GE . 1995 Mol. Cell. Biol. 15: 6702–6709

  • Arsura M, Sonenshein G.E . 2001 Transcription Factors: Normal and Malignant Development of Blood Cells Ravid K and Licht J . (eds) J. Wiley & Sons pp521–549

  • Bellas RE, Lee JS, Sonenshein GE . 1995 J. Clin. Invest. 96: 2521–2527

  • Benhamou L, Cazenave P-A, Sarthou P . 1990 Eur. J. Immunol. 20: 1405–1407

  • Berns E, van Putten KJW, van Staveren I, Portengen H, Foekens J . 1992 Cancer Res. 52: 1107–1113

  • Besancon F, Atfi A, Gespach C, Cayre YE, Bourgeade MF . 1998 Proc. Natl. Acad. Sci. USA 95: 8081–8086

  • Bond J, Farmer SR . 1983 Mol. Cell. Biol. 3: 1333–1342

  • Borg A, Baldetorp B, Ferno M, Olsson H, Sigurdsson H . 1992 Eur. J. Cancer 51: 687–691

  • Bouchard C, Thieke K, Maier A, Saffrich R, Hanley-Hyde J, Ansorge W, Reed S, Sicinski P, Bartek J, Eilers M . 1999 EMBO J. 18: 5321–5333

  • Boyd A, Schrader J . 1981 J. Immunol. 126: 2466–2469

  • Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI, Slingerland JM . 1997 Nature Med. 3: 227–230

  • Chen D, Krasinski K, Sylvester A, Chen J, Nisen PD, Andres V . 1997 J. Clin. Invest. 99: 2334–2341

  • Clark HM, Yano T, Otsuki T, Jaffe ES, Shibata D, Raffeld M . 1994 Cancer Res. 54: 3383–3386

  • Classen GF, Hann SR . 1999 Oncogene 18: 2925–2933

  • Classen GF, Hann SR . 2000 Proc. Natl. Acad. Sci. USA 97: 9498–9503

  • Dang CV . 1999 Mol. Cell. Biol. 19: 1–11

  • Dignam JD, Martin PL, Shastry BS, Roeder RG . 1983 Methods Enzymol. 101: 582–598

  • Dmitrovsky E, Kuehl WM, Hollis GF, Kirsch IR, Bender TP, Segal S . 1986 Nature 322: 748–750

  • Ezhevsky S, Toyoshima H, Hunter T, Scott D . 1996 Mol. Biol. Cell 7: 553–564

  • Facchini LM, Penn LZ . 1998 FASEB J. 12: 633–651

  • Facchini LM, Chen S, Marhin WW, Lear JN, Penn LZ . 1997 Mol. Cell Biol. 17: 100–114

  • FitzGerald MJ, Arsura M, Bellas RE, Yang W, Wu M, Chin L, Mann KK, DePinho RA, Sonenshein GE . 1999 Oncogene 18: 2489–2498

  • Frangioni JV, Neel BG . 1993 Anal. Biochem. 210: 179–187

  • Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A, Badimon JJ . 1999 Circulation 99: 2164–2170

  • Grandori C, Eisenman RN . 1997 Trends Biochem. Sci. 22: 177–181

  • Greenberg ME, Ziff EB . 1984 Nature 311: 433–438

  • Hackett AJ, Smith HS, Springer EL, Owens RB, Nelson-Rees WA, Riggs JL, Gardner MB . 1977 J. Nat. Cancer Inst. 58: 1795–1806

  • Hann SR, Dixit V, Sears RC, Sealy L . 1994 Genes Dev. 8: 2441–2452

  • Hengst L, Reed SI . 1996 Science 271: 1861–1864

  • Hoang A, Lutterbach B, Lewis BC, Yano T, Chou T, Barrett J, Raffeld M, Hann SR, Dang CV . 1995 Mol. Cell. Biol. 15: 4031–4042

  • Hopewell R, Ziff EB . 1995 Mol. Cell Biol. 15: 3470–3478

  • Iritani BM, Eisenman RN . 1999 Proc. Natl. Acad. Sci. USA 96: 13180–13185

  • Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T . 1998 J. Immunol. 160: 770–777

  • Kihara-Newgishi F, Yamada T, Kubota Y, Kondah N, Yamamoto H, Abe M, Shirai T, Hashimoto Y, Oikawa T . 1998 Int. J. Cancer 18: 523–530

  • Kim M, Katayose Y, Li Q, Rakkar AN, Li Z, Hwang SG, Katayose D, Trepel J, Cowan KH, Seth P . 1998 Biochem. Biophys. Res. Commun. 253: 672–677

  • Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmuller U, Nakajima K, Hirano T, Horn F, Behrmann I . 1999 Oncogene 18: 3742–3753

  • Kwon T, Nagel J, Bucholz M, Nordin A . 1996 Gene 180: 113–120

  • Kypreos KE, Marhamati DJ, Sonenshein GE . 1999 Matrix Biology 18: 275–285

  • Land H, Chen AC, Morgenstern JP, Parada LF, Weinberg RA . 1986 Mol. Cell Biol. 6: 1917–1925

  • Lee CC, Ichihara T, Yamamoto S, Wanibuchi H, Sugimura K, Wada S, Kishimoto T, Fukushima S . 1999 Carcinogenesis 20: 1697–1708

  • Lee LA, Dang CV . 1997 Curr. Topics Micro. Immunol. 224: 131–135

  • Lee H, Arsura M, Wu M, Duyao M, Buckler AJ, Sonenshein GE . 1995 J. Exp. Med. 181: 1169–1177

  • Lee LA, Dolde C, Barrett J, Wu CS, Dang CV . 1996 J. Clin. Investig. 97: 1687–1695

  • Lee TC, Li L, Philipson L, Ziff EB . 1997 Proc. Natl Acad Sci USA 94: 12886–12891

  • Lemaitre J-M, Buckle RS, Mechali M . 1996 Adv. Cancer Res. 70: 95–144

  • Levine RA, McCormack JE, Buckler AJ, Sonenshein GE . 1986 Mol. Cell Biol. 6: 4112–4116

  • Li LH, Nerlov C, Prendergast G, MacGregor D, Ziff EB . 1994 EMBO J. 17: 4070–4079

  • Lioyd RV, Erickson LA, Lin L, Kulig E, QianX, Cheville JC, Scheithauer BW . 1999 Am J. Path. 154: 313–323

  • Lo K, Smale ST . 1996 Gene 182: 13–22

  • Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Dratta GF, Jessup JM, Pagano M . 1997 Nature Med. 3: 231–234

  • Maheswaran S, McCormack JE, Sonenshein GE . 1991 Oncogene 6: 1965–1971

  • Mai S, Martensson IL . 1995 Nucleic Acids Res. 23: 1–9

  • Manzano-Winkler R, Novina CD, Roy AL . 1996 J. Biol. Chem. 271: 12076–12081

  • Mateyak MK, Obaya AJ, Adachi S, Sedivy JM . 1997 Cell Growth Differ. 8: 1039–1048

  • Mateyak MK, Obaya AJ, Sedivy JM . 1999 Mol. Cell. Biol. 19: 4672–4683

  • McCormack JE, Pepe VH, Kent RB, Dean M, Marshak-Rothstein A, Sonenshein GE . 1984 Proc. Natl. Acad. Sci. USA 81: 5546–5550

  • Mink S, Mutschler B, Weiskirchen R, Bister K, Klempnauer KH . 1996 Proc. Natl. Acad. Sci. USA 93: 6635–6640

  • Norvell A, Mandik L, Monroe JG . 1995 J. Immunol. 154: 4403–4413

  • Perez-Roger I, Kim SH, Griffiths B, Sewing A, Land H . 1999 EMBO J. 18: 5310–5320

  • Peukert K, Staller P, Schneider A, Carmichael G, Hanel F, Eilers M . 1997 EMBO J. 16: 5672–5686

  • Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A . 1994 Genes Dev. 8: 9–22

  • Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM . 1997 Nature Med. 3: 222–225

  • Prochownik EV, Kukowska J, Rodgers C . 1988 Mol. Cell. Biol. 8: 3683–3695

  • Roy AL, Garruthers C, Gutjahr T, Roeder RG . 1993 Nature 365: 359–361

  • Runge D, Runge DM, Bowen WC, Locker J, Michalopoulos GK . 1997 J. Biol. Chem. 378: 873–881

  • Schauer SL, Wang Z, Sonenshein GE, Rothstein TL . 1996 J. Immunol. 157: 81–86

  • Schauer SL, Bellas RE, Sonenshein GE . 1998 J. Immunol. 160: 4398–4405

  • Sherr C, Roberts JM . 1999 Genes Dev. 13: 1501–1512

  • Shiyanov P, Hayes S, Chen N, Pestov D, Lau L, Raychaudhuri P . 1997 Mol. Biol. Cell. 8: 1815–1827

  • Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE . 1997 J. Clin. Invest. 100: 2952–2960

  • Spencer CA, Groudine M . 1991 Adv. Cancer Res. 56: 1–48

  • Stanton L, Watt R, Marcu K . 1983 Nature 303: 401–406

  • Steiner P, Rudolph B, Muller D, Eilers M . 1996 Prog. Cell Cycle Res. 2: 73–82

  • Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG, Thompson EB . 1998 Circ. Res. 82: 396–403

  • Thompson EB . 1998 Annu. Rev. Physiol. 60: 575–600

  • Toyoshima H, Hunter T . 1994 Cell 78: 67–74

  • Tsihlias J, Kapusta L, Slingerland J . 1999 Annu. Rev. Med. 50: 401–423

  • Tsuchiya A, Zhang GJ, Kanno M . 1999 J. Surg. Oncol. 70: 230–234

  • Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B . 1996 EMBO J. 15: 6595–6604

  • Xiao Q, Claasen G, Shi J, Adachi S, Sedivy J, Hann S . 1998 Genes Dev. 12: 3803–3808

  • Wang W, Wykrzykowska J, Johnson T, Sen R, Sen J . 1999 J. Immunol. 162: 314–322

  • Warner BJ, Blain SW, Seoane J, Massague J . 1999 Mol. Cell. Biol. 19: 5913–5922

  • Warner GL, Ludlow J, Nelson DO, Gaur A, Scott D . 1992 Cell Growth Differ. 3: 175–181

  • Wu M, Arsura M, Bellas RE, FitzGerald MJ, Lee H, Schauer SL, Sherr DH, Sonenshein GE . 1996a Mol. Cell. Biol. 16: 5015–5025

  • Wu M, Bellas RE, Shen J, Sonenshein GE . 1998 J. Exp. Med. 187: 1671–1679

  • Wu M, Bellas RE, Shen J, Yang W, Sonenshein GE . 1999 J. Immunol. 163: 6530–6535

  • Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, FitzGerald MJ, Rothstein TL, Sherr DH, Sonenshein GE . 1996b EMBO J. 15: 4682–4690

  • Yanagisawa K, Kosaka A, Iwahana H, Nakanishi M, Tominaga S . 1999 J. Biochem. (Tokyo) 125: 36–40

  • Yano T, Sander C, Clark H, Dolezal M, Jaffe E, Raffeld M . 1993 Oncogene. 8: 2741–2748

  • Yi AK, Hornbeck P, Lafrenz DE, Krieg AM . 1996 J. Immunol. 157: 4918–4925

Download references

Acknowledgements

We thank Drs C Dang, S Desiderio, S Hann, A Koff, Y Xiong, and E Ziff for generously providing cloned DNAs or antibody preparations. This work was supported by National Institutes of Health grants CA 36355 (GE Sonenshein), HL13262 (GE Sonenshein), and CA 82742 (GE Sonenshein) and training grants HL07429 (W Yang) and CA64070 (MJ FitzGerald), and Department of Army grant DAMD17-98-1-8034 (DW Kim) and Cure for Lymphoma Foundation (M Arsura).

Author information

Author notes

  1. William Yang and Jian Shen: W Yang and J Shen contributed equally to this work.

Authors and Affiliations

  1. Department of Biochemistry, Boston University Medical School, Boston, 02118, Maryland, MA, USA

    William Yang, Jian Shen, Min Wu, Marcello Arsura, Mark FitzGerald, Dong W Kim, Claudia S Hofmann, Stefania Pianetti, Raphaëlle Romieu-Mourez & Gail E Sonenshein

  2. Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, 10021, NY, USA

    Zalman Suldan & Leonard P Freedman

Authors
  1. William Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jian Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Min Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcello Arsura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mark FitzGerald
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zalman Suldan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dong W Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Claudia S Hofmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Stefania Pianetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Raphaëlle Romieu-Mourez
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Leonard P Freedman
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Gail E Sonenshein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, W., Shen, J., Wu, M. et al. Repression of transcription of the p27Kip1 cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20, 1688–1702 (2001). https://doi.org/10.1038/sj.onc.1204245

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204245

Keywords

This article is cited by

Search

Advanced search

Quick links